{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:23:27Z","timestamp":1770744207278,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015101","name":"Chicken Farmers of Saskatchewan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015101","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008921","name":"Saskatchewan Agriculture Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.023","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T15:45:12Z","timestamp":1484063112000},"page":"981-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens"],"prefix":"10.1016","volume":"35","author":[{"given":"Mishal","family":"Sarfraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh K.","family":"Tikoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Wheler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshud","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.12.023_b0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2307\/1587881","article-title":"Avian hepatic inclusion bodies of unknown significance","volume":"7","author":"Helmboldt","year":"1963","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/03079457608418202","article-title":"Experimental studies on the aetiology of inclusion body hepatitis","volume":"5","author":"McCracken","year":"1976","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1637\/9764-041911-Reg.1","article-title":"Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens","volume":"56","author":"Dar","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1637\/10612-071113-Reg.1","article-title":"Flock prevalence of exposure to avian adeno-associated virus, chicken anemia virus, fowl adenovirus, and infectious bursal disease virus among Ontario broiler chicken flocks","volume":"58","author":"Eregae","year":"2014","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1637\/8958-061109-Reg.1","article-title":"Epidemiology and effect on production parameters of an outbreak of inclusion body hepatitis in broilers","volume":"54","author":"Senties-Cue","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1637\/11202-052815-Reg.1","article-title":"Administration of poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and avian beta defensin as adjuvants in inactivated inclusion body hepatitis virus and its hexon protein-based experimental vaccine formulations in chickens","volume":"59","author":"Dar","year":"2015","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0065-3519(99)80037-8","article-title":"In ovo vaccination technology","volume":"41","author":"Ricks","year":"1999","journal-title":"Adv Vet Med"},{"key":"10.1016\/j.vaccine.2016.12.023_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/14760584.6.3.457","article-title":"Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines","volume":"6","author":"Avakian","year":"2007","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2016.12.023_b0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2307\/1593092","article-title":"Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch","volume":"44","author":"Avakian","year":"2000","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2307\/1592620","article-title":"In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents","volume":"43","author":"Gagic","year":"1999","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.addr.2008.12.004","article-title":"Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides","volume":"61","author":"Mutwiri","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.12.023_b0060","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2006.10.011","article-title":"Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1\/Th2 immune responses in mice immunized with influenza virus antigens","volume":"25","author":"Mutwiri","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2012.01.021","article-title":"Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1\/Th2 immune responses in pigs","volume":"146","author":"Dar","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.12.023_b0070","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1136\/ard.62.suppl_2.ii17","article-title":"Roles of antimicrobial peptides such as defensins in innate and adaptive immunity","volume":"62","author":"Oppenheim","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.1201648","article-title":"Beta-defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-alpha production by human plasmacytoid dendritic cells, and promote inflammation","volume":"191","author":"Tewary","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vetimm.2014.05.004","article-title":"CpG-ODNs induced changes in cytokine\/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs","volume":"160","author":"Dar","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2016.12.023_b0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2307\/1591862","article-title":"Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers","volume":"39","author":"Sarma","year":"1995","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/03079450400013220","article-title":"Hatchability, serology and virus excretion following in ovo vaccination of chickens with an avian metapneumovirus vaccine","volume":"33","author":"Hess","year":"2004","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2307\/1592412","article-title":"Embryo vaccination of chickens with infectious bronchitis virus: histologic and ultrastructural lesion response and immunologic response to vaccination","volume":"39","author":"Wakenell","year":"1995","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0264-410X(02)00689-8","article-title":"Immunity to avian pneumovirus infection in turkeys following in ovo vaccination with an attenuated vaccine","volume":"21","author":"Worthington","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/IAI.5.3.300-304.1972","article-title":"Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization","volume":"5","author":"Scott","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.023_b0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/122.4.239","article-title":"Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses","volume":"122","author":"Smith","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0120","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1016\/j.vaccine.2012.10.013","article-title":"A subunit vaccine against hydropericardium syndrome using adenovirus penton capsid protein","volume":"30","author":"Shah","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11250-010-9694-z","article-title":"Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens","volume":"43","author":"Mansoor","year":"2011","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2016.12.023_b0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1637\/0005-2086(2007)051[0027:GCPAPS]2.0.CO;2","article-title":"Genetic characterization, pathogenicity, and protection studies with an avian adenovirus isolate associated with inclusion body hepatitis","volume":"51","author":"Alvarado","year":"2007","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0135","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.vaccine.2014.03.015","article-title":"An inactivated oil-emulsion fowl Adenovirus serotype 4 vaccine provides broad cross-protection against various serotypes of fowl Adenovirus","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1637\/9930-091311-Reg.1","article-title":"Optimization of the protocols for double vaccination against Marek's disease by using commercially available vaccines: evaluation of protection, vaccine replication, and activation of T cells","volume":"56","author":"Gimeno","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1637\/11060-031115-Reg.1","article-title":"In ovo vaccination with turkey herpesvirus hastens maturation of chicken embryo immune responses in specific-pathogen-free chickens","volume":"59","author":"Gimeno","year":"2015","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2016.12.023_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/INF.0b013e31819075a6","article-title":"Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections","volume":"28","author":"Moro","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.12.023_b0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-3024.1997.d01-191.x","article-title":"Peripheral blood lymphocytes from Eimeria tenella infected chickens produce gamma-interferon after stimulation in vitro","volume":"19","author":"Breed","year":"1997","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-1759(96)00026-9","article-title":"Nitric oxide inducing factor as a measure of antigen and mitogen-specific T cell responses in chickens","volume":"192","author":"Karaca","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.12.023_b0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/0307945042000220318","article-title":"Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation","volume":"33","author":"Lambrecht","year":"2004","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0175","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.12.023_b0180","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.4049\/jimmunol.178.6.3505","article-title":"Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus","volume":"178","author":"Zhu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0185","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1016\/j.vaccine.2011.07.009","article-title":"Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis","volume":"29","author":"Garlapati","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0190","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.vaccine.2008.03.031","article-title":"Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen","volume":"26","author":"Mutwiri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0195","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.vaccine.2014.03.014","article-title":"The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node","volume":"32","author":"Awate","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.023_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01533364","article-title":"Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency","volume":"14","author":"Chehimi","year":"1994","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/324073a0","article-title":"Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin","volume":"324","author":"Hirano","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.12.023_b0210","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.12.023_b0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2310\/6650.2005.53605","article-title":"Innate immune response to adenovirus","volume":"53","author":"Nazir","year":"2005","journal-title":"J Investig Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:06:30Z","timestamp":1749881190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X16312300"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}